Peer Reviewed Scientific Publications

A curated collection of our latest peer-reviewed research and scientific contributions.

Journals We Have Published In

Latest Publications

Systematic and quantitative analyses of hollow fiber model of Mycobacterium abscessus lung disease studies and new dosing recommendations

April 21, 2026

Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions

March 31, 2026

Rifamycin-, macrolide-, and ethambutol-free combinations to treat Mycobacterium avium complex lung disease

February 27, 2026

Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease

February 1, 2026

Pharmacodynamic evidence for tedizolid use in Mycobacterium avium lung disease

January 9, 2026

Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung disease

January 6, 2026

Eravacycline pharmacokinetics/pharmacodynamics in the hollow fiber system model of Mycobacterium abscessus lung disease

January 6, 2026

Tigecycline pharmacodynamics in the hollow fiber system of Mycobacterium avium-complex lung disease and the utility of MICs and time-kill studies in drug development

November 12, 2025

Epetraborole pharmacokinetics/pharmacodynamics in the hollow fiber system model of Mycobacterium tuberculosis

November 5, 2025

Sulbactam-durlobactam improves cephalosporin and carbapenem susceptibility and time-kill effect against Mycobacterium abscessus

October 7, 2025

Ceftaroline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium abscessus lung disease

September 10, 2025